Publications by authors named "Andrew R Crow"

Claim this Profile
T
Treating murine inflammatory diseases with an anti-erythrocyte antibody.
Andrew R Crow, Rick Kapur, Sandra Koernig, Ian K Campbell, Chao-Ching Jen

Sci Transl Med· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanistic properties of intravenous immunoglobulin in murine immune thrombocytopenia: support for FcγRIIB falls by the wayside.
Andrew R Crow, Alan H Lazarus

Semin Hematol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD44 antibody-mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of FcγRIIb genetic disruption.
Andrew R Crow, Alaa Amash, Alan H Lazarus

Transfusion· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amelioration of murine passive immune thrombocytopenia by IVIg and a therapeutic monoclonal CD44 antibody does not require the Myd88 signaling pathway.
Andrew R Crow, Honghui Yu, Dongji Han, Alan H Lazarus

PLoS One· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The neonatal Fc receptor (FcRn) is not required for IVIg or anti-CD44 monoclonal antibody-mediated amelioration of murine immune thrombocytopenia.
Andrew R Crow, Sara J Suppa, Xi Chen, Patrick J Mott, Alan H Lazarus

Blood· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amelioration of murine immune thrombocytopenia by CD44 antibodies: a potential therapy for ITP?
Andrew R Crow, Seng Song, Sara J Suppa, Shuhua Ma, Michael P Reilly

Blood· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transfusion of antibody-opsonized red blood cells results in a shift in the immune response from the red blood cell to the antibody in a murine model.
Davor Brinc, Hoang Le-Tien, Andrew R Crow, John W Semple, John Freedman

Transfusion· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk.
Anna Podolanczuk, Alan H Lazarus, Andrew R Crow, Elliot Grossbard, James B Bussel

Blood· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transfusion of IgG-opsonized foreign red blood cells mediates reduction of antigen-specific B cell priming in a murine model.
Davor Brinc, Hoang Le-Tien, Andrew R Crow, Vinayakumar Siragam, John Freedman

J Immunol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoglobulin G-mediated regulation of the murine immune response to transfused red blood cells occurs in the absence of active immune suppression: implications for the mechanism of action of anti-D in the prevention of haemolytic disease of the fetus and newborn?
Davor Brinc, Hoang Le-Tien, Andrew R Crow, Vinayakumar Siragam, John Freedman

Immunology· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mechanisms of action of intravenous immunoglobulin and polyclonal anti-d immunoglobulin in the amelioration of immune thrombocytopenic purpura: what do we really know?
Andrew R Crow, Alan H Lazarus

Transfus Med Rev· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IgG-mediated immunosuppression is not dependent on erythrocyte clearance or immunological evasion: implications for the mechanism of action of anti-D in the prevention of haemolytic disease of the newborn?
Davor Brinc, Hoang Le-Tien, Andrew R Crow, John Freedman, Alan H Lazarus

Br J Haematol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg?
Andrew R Crow, Seng Song, John W Semple, John Freedman, Alan H Lazarus

Blood· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopenia.
Andrew R Crow, Seng Song, Vinayakumar Siragam, Alan H Lazarus

Pediatr Blood Cancer· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells.
Vinayakumar Siragam, Andrew R Crow, Davor Brinc, Seng Song, John Freedman

Nat Med· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo.
Rukhsana Aslam, Edwin R Speck, Michael Kim, Andrew R Crow, K W Annie Bang

Blood· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal antibodies that mimic the action of anti-D in the amelioration of murine ITP act by a mechanism distinct from that of IVIg.
Seng Song, Andrew R Crow, Vinayakumar Siragam, John Freedman, Alan H Lazarus

Blood· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?
Vinayakumar Siragam, Davor Brinc, Andrew R Crow, Seng Song, John Freedman

J Clin Invest· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Fcgamma receptors in the pathogenesis and treatment of idiopathic thrombocytopenic purpura.
Andrew R Crow, Alan H Lazarus

J Pediatr Hematol Oncol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity.
Andrew R Crow, Seng Song, John Freedman, Cheryl D Helgason, R Keith Humphries

Blood· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism of action of IVIG and anti-D in ITP.
Alan H Lazarus, Andrew R Crow

Transfus Apher Sci· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG.
Seng Song, Andrew R Crow, John Freedman, Alan H Lazarus

Blood· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IVIG induces dose-dependent amelioration of ITP in rodent models.
Andrew R Crow, Seng Song, John W Semple, John Freedman, Alan H Lazarus

Blood· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding platelet function through signal transduction.
Alan H Lazarus, Seng Song, Andrew R Crow

Transfus Med Rev· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis